MDxHealth SA (OTCMKTS:MXDHF – Get Free Report)’s share price traded down 9.1% on Monday . The stock traded as low as $0.25 and last traded at $0.25. 300 shares were traded during mid-day trading, a decline of 70% from the average session volume of 1,000 shares. The stock had previously closed at $0.28.
MDxHealth Price Performance
The company has a quick ratio of 1.19, a current ratio of 1.25 and a debt-to-equity ratio of 1.45. The business has a 50-day moving average of $0.43.
MDxHealth Company Profile
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications.
Read More
- Five stocks we like better than MDxHealth
- What is the Euro STOXX 50 Index?
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- Russell 2000 Index, How Investors Use it For Profitable Trading
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- How to Calculate Stock Profit
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for MDxHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDxHealth and related companies with MarketBeat.com's FREE daily email newsletter.